Evidence map›Paper›PMID 32292578›Full record

ArticleOncotarget2020

Correction: Exclusive destruction of mitotic spindles in human cancer cells.

Leonid Visochek, Asher Castiel, Leonid Mittelman, Michael Elkin, Dikla Atias, Talia Golan, Shai Izraeli, Tamar Peretz, Malka Cohen-Armon

Abstract readPublished Erratum
In one paragraph

Article in Oncotarget, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Leonid VisochekThe Neufeld Cardiac Research Institute, Department of Physiology and Pharmacology, Sackler School of Medicine, Tel-Aviv University, Tel-Aviv 69978, Israel.
Asher CastielCancer Research Center, Sheba Medical Center, Ramat Gan 53621, Israel.
Leonid MittelmanThe Imaging Unit, Sackler School of Medicine, Tel-Aviv University, Tel-Aviv 69978, Israel.
Michael ElkinSharett Oncology Institute, Hadassah Medical Center, Ein-Kerem, Jerusalem 91120, Israel.
Dikla AtiasCancer Research Center, Sheba Medical Center, Ramat Gan 53621, Israel.
Talia GolanCancer Research Center, Sheba Medical Center, Ramat Gan 53621, Israel.
Shai IzraeliCancer Research Center, Sheba Medical Center, Ramat Gan 53621, Israel.
Tamar PeretzSharett Oncology Institute, Hadassah Medical Center, Ein-Kerem, Jerusalem 91120, Israel.
Malka Cohen-ArmonThe Neufeld Cardiac Research Institute, Department of Physiology and Pharmacology, Sackler School of Medicine, Tel-Aviv University, Tel-Aviv 69978, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.18632/oncotarget.15343.].

Identifiers

PMID32292578
PMCPMC7147084

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.